Quick test for detecting dengue virus infections
Rapid Point-of-Care RNA Diagnostic for Dengue Infection
['FUNDING_SBIR_2'] · CROSSLIFE TECHNOLOGIES, INC. · NIH-10469689
This study is working on a quick and easy test for dengue virus that can give results in just 30 minutes using a simple paper strip, making it perfect for people in tropical areas who need fast answers without complicated lab equipment.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CROSSLIFE TECHNOLOGIES, INC. (nih funded) |
| Locations | 1 site (CARLSBAD, UNITED STATES) |
| Trial ID | NIH-10469689 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a rapid point-of-care diagnostic test for dengue virus infections, which are prevalent in tropical regions. The test aims to provide results within 30 minutes using a simple paper strip, allowing for immediate treatment decisions. By utilizing a novel Template Assisted Rapid Assay (TARA) technology, the diagnostic can detect the virus directly from whole blood samples without the need for complex laboratory equipment. This approach is particularly beneficial in areas where traditional testing methods are unavailable or too slow.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing symptoms of dengue fever, particularly in endemic regions of Southeast Asia and Latin America.
Not a fit: Patients who are not in areas where dengue is endemic or those who do not exhibit symptoms of dengue infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster diagnosis and treatment of dengue infections, potentially saving lives and reducing the spread of the virus.
How similar studies have performed: Other research has shown promise in developing rapid diagnostic tests for infectious diseases, indicating that this approach could be effective for dengue as well.
Where this research is happening
CARLSBAD, UNITED STATES
- CROSSLIFE TECHNOLOGIES, INC. — CARLSBAD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHO, HYUNDAE — CROSSLIFE TECHNOLOGIES, INC.
- Study coordinator: CHO, HYUNDAE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.